Transcriptomics

Dataset Information

0

MYCN drives glutaminolysis in neuroblastoma and confers sensitivity to ROS augmenting agents


ABSTRACT: Through a small scale metabolic-modulator screening, we have identified dimethyl fumarate (DMF), a FDA approved drug for multiple sclerosis, which suppresses neuroblastoma cell growth in vitro and in vivo. Mechanistically, DMF suppresses neuroblastoma cell growth through inducing ROS and subsequently suppressing MYCN expression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE98241 | GEO | 2018/04/18

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-05-01 | GSE98733 | GEO
| S-EPMC5833827 | biostudies-literature
2016-08-31 | MSV000080111 | MassIVE
2018-07-30 | GSE97328 | GEO
2020-12-10 | GSE63361 | GEO
2020-12-10 | GSE63343 | GEO
2022-10-26 | GSE215450 | GEO
2024-09-30 | GSE274435 | GEO
2024-09-30 | GSE274859 | GEO
2015-12-31 | E-MTAB-2406 | biostudies-arrayexpress